The nasal microbiome modulates risk for SARS-CoV-2 infection
Research reported in this article was supported by the Milken Institute School of Public Health, the George Washington University and the National Institute of Allergy and Infectious Diseases, National Institutes of Health under award number R01AI168182. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Authors
- Bruce A. Hungate (ORCID: https://orcid.org/0000-0002-7337-1887)
- Cindy Meng-Hsin Liu (ORCID: https://orcid.org/0000-0003-4537-173X)
- Tony Pham (ORCID: https://orcid.org/0000-0001-5654-163X)
- Lance Bradley Price (ORCID: https://orcid.org/0000-0002-8746-5307)
- Nathan O Weber
- Juan E. Salazar (ORCID: https://orcid.org/0000-0003-1093-4926)
- Jack Villani (ORCID: https://orcid.org/0000-0002-8219-1917)
- Daniel E. Park (ORCID: https://orcid.org/0000-0001-5139-5397)
- Maliha Aziz (ORCID: https://orcid.org/0000-0002-8347-5487)
- Sydney G. Nelson
Institutions
- Milken Institute (US)
- George Washington University (US)
- Northern Arizona University (US)
Publication Details
- Journal
- EBioMedicine
- Published
- 2025-04-09
- DOI
- https://doi.org/10.1016/j.ebiom.2025.105660
- Citations
- 2
- Primary Topic
- Dental Research and COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 5.65